Form 8-K - Current report:
SEC Accession No. 0001144204-19-014679
Filing Date
2019-03-18
Accepted
2019-03-18 17:17:34
Documents
3
Period of Report
2019-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv516476_8k.htm 8-K 17296
2 EXHIBIT 99.1 tv516476_ex99-1.htm EX-99.1 121816
3 GRAPHIC image_001.jpg GRAPHIC 21437
  Complete submission text file 0001144204-19-014679.txt   170015
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 19689212
SIC: 2834 Pharmaceutical Preparations